Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 449

Motiv Power pulls in $15m

GMAg provided $15m in convertible note financing that will be put towards the Winnebago-backed electrification equipment maker's ongoing series C round.

Aug 27, 2020

SparkMeter measures $12m in series A funding

Total Energy Ventures helped the utility-scale energy meter provider close a round that will support the launch of its latest software product.

Aug 27, 2020

Cisco signs up for BabbleLabs acquisition

Dell Technologies Capital and Intel Capital are set to exit the audio enhancement technology provider, which has agreed to be bought by Cisco.

Aug 26, 2020

Daily deal net: August 26, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 26, 2020

Palantir reveals filing for direct listing

The Sompo, Fujitsu and Relx-backed data miner, which has raised some $2.7bn in venture funding, has chosen the New York Stock Exchange to list its shares.

Aug 26, 2020

Bionano Genomics takes up Lineagen

University of Utah autism diagnosis service provider Lineagen has been snapped up in a transaction worth at least $9.6m in cash, stocks and liabilities.

Aug 26, 2020

Lyra Health rings in $110m series D

Mental health benefits provider Lyra Health once again secured funding from Providence Ventures, as part of a round that pushed its valuation to $1.1bn.

Aug 26, 2020

Mural raises $118m more

Corporate venturing units Slack Fund and Gradient Ventures contributed to a series B round that increased the online whiteboard developer's total funding to about $143m.

Aug 26, 2020

Yumanity and Proteostasis pursue reverse merger

Yumanity Therapeutics will take over Nasdaq-listed Proteostasis in a reverse merger after raising more than $100m from investors including Biogen, Merck & Co, Pfizer and Sanofi.

Aug 26, 2020

Acadia absorbs Cersci for $52.5m

UT Dallas spinout Cersci Therapeutics has been acquired in a deal potentially worth nearly $940m, including a $52.5m upfront payment.

Aug 26, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here